HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir. (2016)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jhep.2016.02.022

PubMed Identifier: 26907973

Publication URI: http://europepmc.org/abstract/MED/26907973

Type: Journal Article/Review

Volume: 64

Parent Publication: Journal of hepatology

Issue: 6

ISSN: 0168-8278